|
Aug 27
|
Pfizer launches new telehealth and prescription drug platform
|
|
Aug 3
|
2 Ultra-High-Yield Dividend Stocks to Buy in August and Hold at Least a Decade
|
|
Aug 3
|
Is This Decision by Pfizer Bad News for Eli Lilly?
|
|
Aug 3
|
About half of US state AGs went on France trip sponsored by group with lobbyist and corporate funds
|
|
Aug 2
|
Can Pfizer (PFE) Run Higher on Rising Earnings Estimates?
|
|
Aug 2
|
Pfizer’s haemophilia A gene therapy shows promise, but tough rivals ahead
|
|
Aug 2
|
Revenge Of The Rest: These Three S&P 493 Stocks Are Set To Pop
|
|
Aug 2
|
PFE vs. NVO: Which Stock Is the Better Value Option?
|
|
Aug 2
|
Are Investors Undervaluing Pfizer (PFE) Right Now?
|
|
Aug 2
|
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
|
|
Aug 2
|
Is Pfizer Winning Its $43 Billion Bet?
|
|
Aug 1
|
Who's to blame as Moderna's stock falls amid slashed guidance?
|
|
Aug 1
|
Moderna Earnings Beat Estimates. Why the Stock Is Sinking.
|
|
Aug 1
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Aug 1
|
Pfizer Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 1
|
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
|
|
Aug 1
|
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
|
|
Aug 1
|
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
|
|
Jul 31
|
Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023
|
|
Jul 31
|
Company News for Jul 31, 2024
|